Central nervous system bleeding in hemophiliacs

M. E. Eyster, F. M. Gill, P. M. Blatt, M. W. Hilgartner, J. O. Ballard, T. R. Kinney

Research output: Contribution to journalArticle

137 Citations (Scopus)

Abstract

From an estimated population of 2500 hemophiliacs seen between 1965 and 1976, 71 with documented central nervous system (CNS) bleeding were studied retrospectively: 56 had factor VIII deficiency and 15 had factor IX deficiency. More than two-thirds were less than 18 yr old, and one-third were age 3 yr or less when CNS bleeding occurred. Thirty-eight (54%) had a history of recent trauma; one-half of these had a long symptom-free interval of 4 ± 2.2 days (1 SD). Four had hypertension and three had underlying congenital anomalies. No etiology was apparent in 38%. Sixty-five patients had intracranial bleeding. Those with intracerebral bleeding had a poorer prognosis than did those with subarachnoid or subdural bleeding. Intraspinal bleeding occurred in six patients. The combined mortality rate was 34%. Of 47 survivors, 12 (26%) had recurrent bleeding in the absence of known trauma. Recurrent bleeding 1 yr or more after the initial episodes seemed to be more common in factor IX-deficient than in factor VIII-deficient patients. Clotting factor concentrates to maintain minimum blood levels at 30%-50% of normal were usually given for at least 10-14 days in those who survived. Forty-seven percent (22 of 47 survivors) had neurologic sequelae, such as mental retardation, seizure disorders, or motor impairment. From these observations we conclude that the evaluation and treatment of intracranial bleeding in hemophiliacs should include (1) prompt replacement therapy with factor VIII or IX for either cranial-spinal axis trauma or CNS signs and symptoms in the absence of a history of trauma, (2) documentation of bleeding by computerized tomography scanning or other diagnostic techniques, and (3) prolonged replacement therapy in patients with documented CNS bleeding.

Original languageEnglish (US)
Pages (from-to)1179-1188
Number of pages10
JournalBlood
Volume51
Issue number6
StatePublished - Dec 1 1978

Fingerprint

Neurology
Factor IX
Factor VIII
Central Nervous System
Hemorrhage
Blood Coagulation Factors
Computerized tomography
Blood
Wounds and Injuries
Scanning
Survivors
Epilepsy, Partial, Motor
Hemophilia B
Hemophilia A
Intellectual Disability
Documentation
Nervous System
Signs and Symptoms
Therapeutics
Tomography

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Eyster, M. E., Gill, F. M., Blatt, P. M., Hilgartner, M. W., Ballard, J. O., & Kinney, T. R. (1978). Central nervous system bleeding in hemophiliacs. Blood, 51(6), 1179-1188.
Eyster, M. E. ; Gill, F. M. ; Blatt, P. M. ; Hilgartner, M. W. ; Ballard, J. O. ; Kinney, T. R. / Central nervous system bleeding in hemophiliacs. In: Blood. 1978 ; Vol. 51, No. 6. pp. 1179-1188.
@article{338a199cf81245e1a80bbab93e952f3a,
title = "Central nervous system bleeding in hemophiliacs",
abstract = "From an estimated population of 2500 hemophiliacs seen between 1965 and 1976, 71 with documented central nervous system (CNS) bleeding were studied retrospectively: 56 had factor VIII deficiency and 15 had factor IX deficiency. More than two-thirds were less than 18 yr old, and one-third were age 3 yr or less when CNS bleeding occurred. Thirty-eight (54{\%}) had a history of recent trauma; one-half of these had a long symptom-free interval of 4 ± 2.2 days (1 SD). Four had hypertension and three had underlying congenital anomalies. No etiology was apparent in 38{\%}. Sixty-five patients had intracranial bleeding. Those with intracerebral bleeding had a poorer prognosis than did those with subarachnoid or subdural bleeding. Intraspinal bleeding occurred in six patients. The combined mortality rate was 34{\%}. Of 47 survivors, 12 (26{\%}) had recurrent bleeding in the absence of known trauma. Recurrent bleeding 1 yr or more after the initial episodes seemed to be more common in factor IX-deficient than in factor VIII-deficient patients. Clotting factor concentrates to maintain minimum blood levels at 30{\%}-50{\%} of normal were usually given for at least 10-14 days in those who survived. Forty-seven percent (22 of 47 survivors) had neurologic sequelae, such as mental retardation, seizure disorders, or motor impairment. From these observations we conclude that the evaluation and treatment of intracranial bleeding in hemophiliacs should include (1) prompt replacement therapy with factor VIII or IX for either cranial-spinal axis trauma or CNS signs and symptoms in the absence of a history of trauma, (2) documentation of bleeding by computerized tomography scanning or other diagnostic techniques, and (3) prolonged replacement therapy in patients with documented CNS bleeding.",
author = "Eyster, {M. E.} and Gill, {F. M.} and Blatt, {P. M.} and Hilgartner, {M. W.} and Ballard, {J. O.} and Kinney, {T. R.}",
year = "1978",
month = "12",
day = "1",
language = "English (US)",
volume = "51",
pages = "1179--1188",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "6",

}

Eyster, ME, Gill, FM, Blatt, PM, Hilgartner, MW, Ballard, JO & Kinney, TR 1978, 'Central nervous system bleeding in hemophiliacs', Blood, vol. 51, no. 6, pp. 1179-1188.

Central nervous system bleeding in hemophiliacs. / Eyster, M. E.; Gill, F. M.; Blatt, P. M.; Hilgartner, M. W.; Ballard, J. O.; Kinney, T. R.

In: Blood, Vol. 51, No. 6, 01.12.1978, p. 1179-1188.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Central nervous system bleeding in hemophiliacs

AU - Eyster, M. E.

AU - Gill, F. M.

AU - Blatt, P. M.

AU - Hilgartner, M. W.

AU - Ballard, J. O.

AU - Kinney, T. R.

PY - 1978/12/1

Y1 - 1978/12/1

N2 - From an estimated population of 2500 hemophiliacs seen between 1965 and 1976, 71 with documented central nervous system (CNS) bleeding were studied retrospectively: 56 had factor VIII deficiency and 15 had factor IX deficiency. More than two-thirds were less than 18 yr old, and one-third were age 3 yr or less when CNS bleeding occurred. Thirty-eight (54%) had a history of recent trauma; one-half of these had a long symptom-free interval of 4 ± 2.2 days (1 SD). Four had hypertension and three had underlying congenital anomalies. No etiology was apparent in 38%. Sixty-five patients had intracranial bleeding. Those with intracerebral bleeding had a poorer prognosis than did those with subarachnoid or subdural bleeding. Intraspinal bleeding occurred in six patients. The combined mortality rate was 34%. Of 47 survivors, 12 (26%) had recurrent bleeding in the absence of known trauma. Recurrent bleeding 1 yr or more after the initial episodes seemed to be more common in factor IX-deficient than in factor VIII-deficient patients. Clotting factor concentrates to maintain minimum blood levels at 30%-50% of normal were usually given for at least 10-14 days in those who survived. Forty-seven percent (22 of 47 survivors) had neurologic sequelae, such as mental retardation, seizure disorders, or motor impairment. From these observations we conclude that the evaluation and treatment of intracranial bleeding in hemophiliacs should include (1) prompt replacement therapy with factor VIII or IX for either cranial-spinal axis trauma or CNS signs and symptoms in the absence of a history of trauma, (2) documentation of bleeding by computerized tomography scanning or other diagnostic techniques, and (3) prolonged replacement therapy in patients with documented CNS bleeding.

AB - From an estimated population of 2500 hemophiliacs seen between 1965 and 1976, 71 with documented central nervous system (CNS) bleeding were studied retrospectively: 56 had factor VIII deficiency and 15 had factor IX deficiency. More than two-thirds were less than 18 yr old, and one-third were age 3 yr or less when CNS bleeding occurred. Thirty-eight (54%) had a history of recent trauma; one-half of these had a long symptom-free interval of 4 ± 2.2 days (1 SD). Four had hypertension and three had underlying congenital anomalies. No etiology was apparent in 38%. Sixty-five patients had intracranial bleeding. Those with intracerebral bleeding had a poorer prognosis than did those with subarachnoid or subdural bleeding. Intraspinal bleeding occurred in six patients. The combined mortality rate was 34%. Of 47 survivors, 12 (26%) had recurrent bleeding in the absence of known trauma. Recurrent bleeding 1 yr or more after the initial episodes seemed to be more common in factor IX-deficient than in factor VIII-deficient patients. Clotting factor concentrates to maintain minimum blood levels at 30%-50% of normal were usually given for at least 10-14 days in those who survived. Forty-seven percent (22 of 47 survivors) had neurologic sequelae, such as mental retardation, seizure disorders, or motor impairment. From these observations we conclude that the evaluation and treatment of intracranial bleeding in hemophiliacs should include (1) prompt replacement therapy with factor VIII or IX for either cranial-spinal axis trauma or CNS signs and symptoms in the absence of a history of trauma, (2) documentation of bleeding by computerized tomography scanning or other diagnostic techniques, and (3) prolonged replacement therapy in patients with documented CNS bleeding.

UR - http://www.scopus.com/inward/record.url?scp=0018138780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018138780&partnerID=8YFLogxK

M3 - Article

C2 - 647123

AN - SCOPUS:0018138780

VL - 51

SP - 1179

EP - 1188

JO - Blood

JF - Blood

SN - 0006-4971

IS - 6

ER -

Eyster ME, Gill FM, Blatt PM, Hilgartner MW, Ballard JO, Kinney TR. Central nervous system bleeding in hemophiliacs. Blood. 1978 Dec 1;51(6):1179-1188.